Acne vulgaris Clinical Trials

17 recruitingLast updated: May 11, 2026

There are 17 actively recruiting acne vulgaris clinical trials across 10 countries. Studies span Not Applicable, Early Phase 1, Phase 3, Phase 4, Phase 2. Top locations include Brest, France, Auxerre, France, Bordeaux, Aquitaine, France. Updated daily from ClinicalTrials.gov.


Acne vulgaris Trials at a Glance

17 actively recruiting trials for acne vulgaris are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Brest, Auxerre, and Bordeaux. Lead sponsors running acne vulgaris studies include Atacama Therapeutics Australia, Pty Ltd., Badr University, and Aswan University.

Browse acne vulgaris trials by phase

Treatments under study

About Acne vulgaris Clinical Trials

Looking for clinical trials for Acne vulgaris? There are currently 22 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Acne vulgaris trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Acne vulgaris clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Phase 4

Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.

Acne vulgaris
Integrative Skin Science and Research30 enrolled1 locationNCT07544251
Recruiting
Early Phase 1

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

Acne vulgariserythemaPost Inflammtory Erythema
Pham Ngoc Thach University of Medicine60 enrolled1 locationNCT07474883
Recruiting
Not Applicable

Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study

Acne vulgaris
Shenyang Medical College220 enrolled1 locationNCT07056673
Recruiting
Phase 3

A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris

Acne vulgaris
Galderma R&D561 enrolled1 locationNCT07186413
Recruiting
Early Phase 1

Weekly Isotretinoin vs Tetracycline for Moderate Acne

Acne vulgaris
Medical University of South Carolina50 enrolled1 locationNCT06225570
Recruiting
Phase 4

Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris

Acne vulgaris
Badr University120 enrolled1 locationNCT07102186
Recruiting
Phase 3

Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris

Acne vulgaris
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.692 enrolled1 locationNCT06403501
Recruiting
Not Applicable

Assessment of Serum Catestatin Level in Acne Vulgaris Patients

Acne vulgaris
Aswan University60 enrolled1 locationNCT07054398
Recruiting
Early Phase 1

Efficacy of Dihydroartemisinin for Treating Acne Vulgaris

Acne vulgaris
Shanghai Zhongshan Hospital60 enrolled1 locationNCT07007078
Recruiting
Phase 3

Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients

Acne vulgaris
Centre Hospitalier Universitaire de Nice420 enrolled16 locationsNCT06447480
Recruiting
Not Applicable

Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder

Acne vulgarisVascular LesionExcessive Hairiness+1 more
Eurofeedback85 enrolled5 locationsNCT06655129
Recruiting
Not Applicable

Vitamin D Supplementation in Acne

Acne vulgaris
HITEC-Institute of Medical Sciences58 enrolled1 locationNCT06141330
Recruiting
Not Applicable

Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia.

Acne vulgaris
Dr.dr.Irma Bernadette, SpKK (K)24 enrolled1 locationNCT06501560
Recruiting
Phase 2

A Phase 2, Proof-of-concept, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AT-5214 in Subjects with Moderate to Severe Facial Acne Vulgaris

Acne vulgaris
Atacama Therapeutics Australia, Pty Ltd.100 enrolled2 locationsACTRN12624000746538
Recruiting
Not Applicable

Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne

Inflammatory Acne Vulgaris
InMode MD Ltd.42 enrolled4 locationsNCT05830968
Recruiting
Not Applicable

Clinical Trial of Microneedle Radiofrequency Combined With Oral Isotretinoin in Moderate to Severe Acne

Moderate to Severe Acne Vulgaris
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University100 enrolled1 locationNCT06378983
Recruiting
Phase 4

Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients

Acne vulgaris
Centre for Human Drug Research, Netherlands30 enrolled1 locationNCT03883269